Proofpoint Capital Research
Investment Thesis
Proofpoint Capital is an operator-led venture capital firm founded in 2025 by Dan Goldsmith, Jonathan Brassington, and Matt Wallach, three longtime collaborators who each scaled a company to a category-defining outcome before becoming investors. The firm's stated positioning is "smart capital for early-stage Vertical AI": they back founders building AI-native software in industries where domain expertise, proprietary data, and distribution flywheels create durable competitive moats. Their pitch to founders is explicitly operational rather than purely financial — "we're more than capital, we're company builders" — and the partners position themselves as hands-on collaborators on go-to-market strategy, fundraising, and scaling decisions rather than passive board observers.
Sector Focus
The firm's core focus is Vertical AI in three industries: Healthcare, Life Sciences, and Financial Services. In sectors where the partners have direct operating experience, they lean on that history; where they haven't lived the industry themselves, they apply what they describe as a repeatable operator's playbook for building and scaling software companies, matched with founders who have deep domain fluency. All three publicly disclosed investments to date are healthcare-adjacent: maritime safety AI, virtual chronic pain care, and specialty-care telehealth infrastructure — with AI/ML as a common enabling layer across the platforms.
Stage Focus
Despite the "early-stage" framing on the firm's homepage, the disclosed deal activity is concentrated at Series A and Series B: a Series A lead in Lin Health, a Series A co-investment in Klinic, and a Series B lead in ShipIn Systems. There is no publicly documented seed or pre-seed activity yet, so stage preferences here should be read as Series A/B rather than pre-seed/seed.
Check Size
No specific check-size range is disclosed on the website or in third-party coverage. Round sizes the firm has participated in span from an $11M Series A (Lin Health) to a $52M Series B (ShipIn Systems), but Proofpoint's individual allocation within each round has not been reported.
Lead Tendency
Mixed. Proofpoint led Lin Health's $11M Series A (December 2025) and ShipIn Systems' $52M Series B (August 2026), and co-invested (not leading) in Klinic's $24M Series A (June 2026) alongside Draper Associates, Wicklow Capital, and others.
Recent Activity
Fund I, L.P. is based in Phoenixville, Pennsylvania and had its first reported sale of securities on January 9, 2026, with a total offering size of up to $200M (per SEC Form D) and roughly $43.9M reported raised to date. The fund appears to be actively deploying: three disclosed investments span December 2025 through August 2026, all in healthcare-adjacent Vertical AI companies.
Portfolio Highlights
- ShipIn (shipin.ai) — Maritime AI: computer vision and AI for commercial fleet safety and efficiency. Raised a $52M Series B in August 2026, led by Proofpoint Capital with Bling Capital, Tokio Marine, HighSage Ventures, Framework Venture Partners, and Zeev Ventures participating.
- Lin Health (lin.health) — Healthcare: AI-based integrative virtual care platform for chronic pain recovery. Raised an $11M Series A in December 2025, led by Proofpoint Capital, with Osage Venture Partners and NewHealth Ventures joining existing investors aMoon, Mayo Clinic, Saban Ventures, and Viola.
- Klinic (klinicai.com) — Healthcare: AI-powered telehealth, access, and therapeutics platform for specialty care, led by CEO Avish Bhama. Raised a $24M Series A around June 2026 with Proofpoint Capital as a co-investor alongside Draper Associates and Wicklow Capital.
Note: the "$30B+ enterprise value built," "$1B+ raised," and "3 companies scaled to IPO & exit" figures on Proofpoint's homepage describe the founding partners' prior operating careers (Veeva Systems, Instructure, LiquidHub, Tendo) — not exits from the Proofpoint fund itself, which is too new to have portfolio exits.
Team
- Matt Wallach, Partner — Co-founder of Veeva Systems, the life-sciences cloud software company that scaled to a multi-billion-dollar public company; also a minority owner of the Philadelphia Union.
- Jonathan Brassington, Co-Founder & Partner — Former CEO of LiquidHub, an enterprise digital consultancy; advisory partner at NewSpring Capital.
- Dan Goldsmith, Co-Founder & Partner — Former President & CEO of Instructure (EdTech, took the company public); co-founder and chairman of Tendo, a healthcare experience software company.
- Melissa Goudey, Finance & Operations — Handles finance and operations for the firm.
Decision Process
The firm is run by three co-founding partners operating as a tight partnership rather than a large investment committee; the partners describe their model publicly as "operators becoming investors," applying shared playbooks from their prior companies to portfolio decisions.
Founder Preferences
Proofpoint's public commentary and portfolio to date suggest a preference for founders building AI-native platforms in regulated, data-rich verticals (healthcare, life sciences, financial services) where the partners' own operating pattern-matching adds the most value — proprietary data, domain expertise, and distribution advantages that compound into defensible moats.
Geographic Focus
Headquartered in Phoenixville, Pennsylvania. Disclosed portfolio companies are US-based (Newton, MA; Denver, CO), and there is no public statement restricting investment to a specific US region.